Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
NGP Energy Capital Management, L.L.C. PR Permian Resources Corp 13D/A 5.7% 2y
August J. Troendle MEDP Medpace Holdings, Inc. 13D/A 19.4% 2y
Spectrum Equity VII, L.P. GDRX GoodRx Holdings, Inc. 13D/A 24.3% 2y
NSV Investments I, L.P. VTYX Ventyx Biosciences, Inc. Common Stock 13D/A 14.2% 2y
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 27.05% 2y
Francisco Partners IV, L.P. GDRX GoodRx Holdings, Inc. 13D/A 42.9% 2y
ROBOTTI ROBERT TDW Tidewater Inc 13D/A 6.5% 2y
Charles Frischer NN Nextnav Inc. 13D 5.3% 2y
GIC Private Ltd CGNX Cognex Corp 13G 5.04% 2y
Laura E. Niklason HUMA Humacyte, Inc. 13D/A 8.4% 2y
JANUS HENDERSON GROUP PLC APLT Applied Therapeutics, Inc. Common Stock 13G 6.1% 2y
NEUBERGER BERMAN GROUP LLC UFPT Ufp Technologies Inc 13G/A 10% 2y
Wealthspring Capital LLC ESHA ESH Acquisition Corp. 13G 10.8% 2y
Capital World Investors MOS Mosaic Co 13G/A 6.1% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC NRC Nrc Health 13G/A 13.38% 2y
Mawer Investment Management Ltd. NOA North American Construction Group Ltd. 13G/A 10.42% 2y
Wealthspring Capital LLC ANSC Agriculture & Natural Solutions Acquisition Corp 13G 10.2% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD NBXG Neuberger Next Generation Connectivity Fund Inc. 13G/A 5% 2y
Capital World Investors LUV Southwest Airlines Co 13G/A 10% 2y
Capital World Investors RRX Regal Rexnord Corp 13G/A 10% 2y
NEUBERGER BERMAN GROUP LLC PLCE Childrens Place, Inc. 13G/A 0.16% 2y
Dodge & Cox IFF International Flavors & Fragrances Inc 13G/A 10.6% 2y
Wealthspring Capital LLC AFJK Aimei Health Technology Co., Ltd. 13G 13.3% 2y
Capital Research Global Investors PNW Pinnacle West Capital Corp 13G/A 11.2% 2y
Lindsell Train Ltd MANU Manchester United plc 13G/A 15.13% 2y
Newtyn Management, LLC MDRX Veradigm Inc. Common Stock 13G 9.6% 2y
Deep Track Capital, LP PYXS Pyxis Oncology, Inc. 13G 7.87% 2y
Foxhaven Asset Management, LP CARG CarGurus, Inc. 13G 5.5% 2y
Blufire Capital Limited EVE EVe Mobility Acquisition Corp 13D 40.5% 2y
Rosenthal Lee FNA Paragon 28, Inc. 13G/A 8.8% 2y
HealthCap VII, L.P. CARM Carisma Therapeutics Inc. 13D/A 8.4% 2y
QVT Financial LP ROIV Roivant Sciences Ltd. 13G/A 8.28% 2y
GENERAL ATLANTIC, L.P. IMCR Immunocore Holdings plc 13D/A 3.5% 2y
Great Hill Equity Partners IV, L.P. INTA Intapp, Inc. 13D/A 9.2% 2y
HealthCap VIII, L.P. SPRB Spruce Biosciences, Inc. 13D/A 8.9% 2y
HealthCap VII, L.P. FUSN Fusion Pharmaceuticals Inc. Common Shares 13D/A 5.3% 2y
Point72 Asset Management, L.P. TERN Terns Pharmaceuticals, Inc. 13G 6.3% 2y
G. Troy Meier SDPI Superior Drilling Products Inc. 13D/A 38.1% 2y
Daqing Mao UK Ucommune International Ltd 13D 17.2% 2y
22NW Fund, LP FARM FARMER BROTHERS CO 13D/A 9.3% 2y
Karpus Management, Inc. EIM Eaton Vance Municipal Bond Fund 13D/A 20.03% 2y
JCP Investment Management, LLC FARM FARMER BROTHERS CO 13D/A 4.7% 2y
Fresenius Medical Care Holdings, Inc. HUMA Humacyte, Inc. 13D/A 15.4% 2y
Maritime Investors Corp. PXS Pyxis Tankers Inc. 13D/A 54.8% 2y
Gold Fields Limited GAU Galiano Gold Inc. 13D/A 19.9% 2y
JAB BevCo B.V. KDP Keurig Dr Pepper Inc. 13D/A 23.9% 2y
HELU CARLOS SLIM TALO Talos Energy Inc. 13G 18.9% 2y
BCPE Watson (DE) BML, LP COHR Coherent Corp. 13D/A 15.6% 2y
THOMPSON DAVIS & CO., INC. SMID Smith Midland Corp 13D/A 28.54% 2y
NOVO HOLDINGS A/S LVTX LAVA Therapeutics N.V. Ordinary Shares 13D/A 0% 2y